Parallel imports into the UK are seriously affecting Pfizer's

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.359, 2002-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Israel to allow parallel drug imports

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 267, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Parallel imports in the enlarged EU: the specific mechanism

By Stothers Christopher

Pharmaceutical Patent Analyst, Vol. 2, Iss. 5, 2013-09 ,pp. : 577-579

Future Science

Access to resources Recommend Favorite

Minimum price difference for parallel imports in Germany?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 419, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

US pharmaceutical manufacturer Pfizer's final effort to overthrow a UK court decision invalidating the PDE-5 patent

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 378, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Parallel importing causes consternation in UK pharma industry

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 298, 2001-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite